Healthcare entity
funding is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention BARDA, the most common co-covered peer. At 7, the average consequence score sits above the same-window beat average of 5.9.
Last mentioned: Mar 19, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
funding is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention BARDA, the most common co-covered peer. At 7, the average consequence score sits above the same-window beat average of 5.9. They are less corroborated than the beat average, carrying 2 original sources each against 3 for the same window. Spectral AI Equity Warrant appears in 1 tracked Healthcare story from March 19, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 30 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Spectral AI Equity Warrant. Shared-story counts are live from our verified record — not editorial picks.
Spectral AI has been awarded $31.7 million in non-dilutive funding from BARDA to accelerate the development and clinical validation of its DeepView® System. This investment aims to enhance AI-driven medical diagnostics for faster, more accurate wound care decisions, particularly in burn and diabetic foot ulcer management.
Source: GlobeNewswire · Benzinga
Spectral AI Equity Warrant is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
